Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03751709
Title Blinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALL
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cedars-Sinai Medical Center
Indications

acute lymphoblastic leukemia

Therapies

Blinatumomab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cedars-Sinai Medical Center Recruiting Los Angeles California 90048 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field